Tin tức & Cập nhật

Prolonged antibiotics use not effective in reducing all-cause, pneumonia 30-day readmissions

05 Aug 2021

Extended use of antibiotic therapy for the treatment of community-onset pneumonia does not appear to reduce the rates of all-cause or pneumonia-specific 30-day readmission, a study has found.

Prolonged antibiotics use not effective in reducing all-cause, pneumonia 30-day readmissions

05 Aug 2021

Pirfenidone superior to nintedanib for preventing acute exacerbation of IPF

05 Aug 2021

Pirfenidone appears to confer greater reduction in the risk of acute exacerbation among patients with idiopathic pulmonary fibrosis (IPF) as compared with nintedanib, as shown in a study.

Pirfenidone superior to nintedanib for preventing acute exacerbation of IPF

05 Aug 2021

Tamsulosin may benefit men with overactive bladder

05 Aug 2021

Short-course treatment with the α-blocker tamsulosin helps reduce overactive bladder (OAB) symptoms in men, a study has found.

Tamsulosin may benefit men with overactive bladder

05 Aug 2021

Adjuvant olaparib extends DFS in high-risk BRCA1/2-mutated HER2-negative early breast cancer

04 Aug 2021 bởi

Adjuvant olaparib for 1 year following local treatment and adjuvant/neoadjuvant chemotherapy improved disease-free survival (DFS) in patients with HER2-negative early breast cancer (EBC) with BRCA1 or BRCA2 pathogenic/likely pathogenic variants and high recurrence risk, according to interim results of the multinational, phase III OlympiA study.

Adjuvant olaparib extends DFS in high-risk BRCA1/2-mutated HER2-negative early breast cancer

04 Aug 2021

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

04 Aug 2021 bởi

The thrombolytic drug alteplase appears to confer survival gains in acute ischaemic stroke patients with atrial fibrillation (AF), especially those who are not undergoing mechanical thrombectomy (MT), as shown in the IAC (Initiation of Anticoagulation After Cardioembolic Stroke) study.

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

04 Aug 2021

mRNA COVID-19 vaccines: Benefits far outweigh the risk

04 Aug 2021 bởi

The benefits of mRNA* COVID-19 vaccines far outweigh the very small risk of vaccine-related myocarditis, says the US Centers for Disease Control and Prevention (CDC).

mRNA COVID-19 vaccines: Benefits far outweigh the risk

04 Aug 2021

CoronaVac: Does it work against the Gamma variant?

03 Aug 2021 bởi

The CoronaVac vaccine shows significantly reduced neutralizing activity against the Gamma variant (previously known as P.1) of SARS-CoV-2 — indicating that the variant may be able to escape immune response in fully vaccinated people as well as reinfect those who had recovered from COVID-19, according to an immunological study presented at ECCMID 2021.

CoronaVac: Does it work against the Gamma variant?

03 Aug 2021

Ixekizumab safe, effective up to 5 years in moderate-to-severe plaque psoriasis

03 Aug 2021 bởi

Treatment with ixekizumab (IXE) for moderate-to-severe plaque psoriasis is consistently safe and effective through 264 weeks in patients using the approved dose, according to the UNCOVER-3 study.

Ixekizumab safe, effective up to 5 years in moderate-to-severe plaque psoriasis

03 Aug 2021

NSAID use not tied to increased COVID-19 severity

02 Aug 2021 bởi

The use of non-steroidal anti-inflammatory drugs (NSAIDs) prior to hospitalization for COVID-19 does not increase the risk of severe COVID-19 outcomes including mortality and requirement for ventilation or supplemental oxygen, according to findings from the ISARIC-CCP-UK* prospective cohort study.

NSAID use not tied to increased COVID-19 severity

02 Aug 2021

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)

02 Aug 2021

New drug applications approved by US FDA as of 16-31 July 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)

02 Aug 2021

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Prolonged antibiotics use not effective in reducing all-cause, pneumonia 30-day readmissions

Prolonged antibiotics use not effective in reducing all-cause, pneumonia 30-day readmissions

Pirfenidone superior to nintedanib for preventing acute exacerbation of IPF

Pirfenidone superior to nintedanib for preventing acute exacerbation of IPF

Tamsulosin may benefit men with overactive bladder

Tamsulosin may benefit men with overactive bladder

Adjuvant olaparib extends DFS in high-risk BRCA1/2-mutated HER2-negative early breast cancer

Adjuvant olaparib extends DFS in high-risk BRCA1/2-mutated HER2-negative early breast cancer

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

mRNA COVID-19 vaccines: Benefits far outweigh the risk

mRNA COVID-19 vaccines: Benefits far outweigh the risk

CoronaVac: Does it work against the Gamma variant?

CoronaVac: Does it work against the Gamma variant?

Ixekizumab safe, effective up to 5 years in moderate-to-severe plaque psoriasis

Ixekizumab safe, effective up to 5 years in moderate-to-severe plaque psoriasis

NSAID use not tied to increased COVID-19 severity

NSAID use not tied to increased COVID-19 severity

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)